# HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs

> **NCT06155123** · — · UNKNOWN · sponsor: **IRCCS National Neurological Institute "C. Mondino" Foundation** · enrollment: 60 (estimated)

## Conditions studied

- Migraine Disorders
- Chronic Migraine
- Episodic Migraine

## Interventions

- **DRUG:** Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs)

## Key facts

- **NCT ID:** NCT06155123
- **Lead sponsor:** IRCCS National Neurological Institute "C. Mondino" Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-14
- **Primary completion:** 2023-09-01
- **Final completion:** 2024-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06155123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06155123, "HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06155123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*